STOCK BASED COMPENSATION (Status of Restricted Stock) (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Performance Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
The weighted average fair value of options granted			$ 5.38	$ 7.24
Dividend yield			0.00%	0.00%
Weighted average risk free interest rate			1.00%	1.00%
Weighted average expected volatility			41.00%	33.50%
Nonvested, Number of Shares [Roll Forward]
Non-vested at beginning of period, Shares	977,504	670,838	580,004	415,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			397,500	417,500
Forfeited during the period, Shares	(86,666)	(0.00)	(86,666)	(26,667)
Vested during the period, Shares			0	(134,995)
Non-vested at end of period, Shares	890,838	670,838	890,838	670,838
Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Non-vested at beginning of the period, Weighted Average Grant Date Fair Value	$ 6.95	$ 8.03	$ 8.02	$ 9.25
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			5.38	7.24
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	7.21	0.00	7.21	8.50
Vested during the period, Weighted Average Grant Date Fair Value			0.00	9.25
Non-vested at end of period, Weighted Average Grant Date Fair Value	$ 6.92	$ 8.03	$ 6.92	$ 8.03
Restricted Stock [Member]
Nonvested, Number of Shares [Roll Forward]
Non-vested at beginning of period, Shares	2,548,625	2,379,975	2,226,375	2,122,225
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	238,500	0	1,224,500	1,033,500
Forfeited during the period, Shares	(213,500)	(31,625)	(254,625)	(151,500)
Vested during the period, Shares	(156,325)	(112,100)	(778,950)	(767,975)
Non-vested at end of period, Shares	2,417,300	2,236,250	2,417,300	2,236,250
Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Non-vested at beginning of the period, Weighted Average Grant Date Fair Value	$ 6.68	$ 8.13	$ 7.87	$ 8.54
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	3.85	0.00	4.78	7.56
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	6.82	8.07	6.99	8.30
Vested during the period, Weighted Average Grant Date Fair Value	6.91	8.71	7.94	8.55
Non-vested at end of period, Weighted Average Grant Date Fair Value	$ 6.38	$ 8.10	$ 6.38	$ 8.10